Christopher P. Molineaux serves as Executive at Aclaris Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Christopher P. Molineaux has executed 15 insider transactions totaling $38.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 1, 2024 involved exercising options for 4,660 shares valued at $0.
Christopher P. Molineaux currently holds 53,163 shares of Aclaris Therapeutics, Inc. (ACRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher P. Molineaux has been a net seller of ACRS stock. They have purchased $0 and sold $38.0K worth of shares.
Christopher P. Molineaux's most recent insider trade was on Jun 1, 2024, when they sold 4,660 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 16,500 |
| $1.41 |
| Discretionary |
| Jun 15, 2023 | ACRS | $301 | Option Exercise | 198 | $1.52 | Discretionary |
| Jun 15, 2023 | ACRS | $37 | Option Exercise | 51 | $0.72 | Discretionary |
| Jun 2, 2023 | ACRS | $0 | Option Exercise | 4,507 | $N/A | Discretionary |
| Jun 3, 2022 | ACRS | $0 | Option Exercise | 3,356 | $N/A | Discretionary |
| Jun 6, 2020 | ACRS | $0 | Option Exercise | 7,333 | $N/A | Discretionary |
| Mar 2, 2020 | ACRS | $0 | Option Exercise | 8,876 | $N/A | Discretionary |
| Apr 6, 2018 | ACRS | $38.0K | Sale | 2,300 | $16.52 | Discretionary |
| Mar 20, 2018 | ACRS | $401 | Option Exercise | 264 | $1.52 | Discretionary |
| Mar 20, 2018 | ACRS | $817 | Option Exercise | 1,993 | $0.41 | Discretionary |
| Mar 20, 2018 | ACRS | $86 | Option Exercise | 120 | $0.72 | Discretionary |
| Mar 17, 2017 | ACRS | $2.7K | Option Exercise | 6,702 | $0.41 | Discretionary |
| Mar 17, 2017 | ACRS | $900 | Option Exercise | 592 | $1.52 | Discretionary |
| Mar 17, 2017 | ACRS | $224 | Option Exercise | 311 | $0.72 | Discretionary |